Immix Biopharma, Inc. (IMMX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Immix Biopharma, Inc. (IMMX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $570.8M, listed on NASDAQ, employing roughly 18 people, carrying a beta of 0.12 to the broader market. Immix Biopharma, Inc. Led by Ilya Rachman, public since 2021-12-16.
Snapshot as of May 15, 2026.
- Spot Price
- $9.96
- Total OI
- 6.5K